Garner Asset Management Corp’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $321K | Sell |
1,729
-140
| -7% | -$26K | 0.15% | 128 |
|
|
2025
Q1 | $392K | Sell |
1,869
-81
| -4% | -$17K | 0.17% | 125 |
|
|
2024
Q4 | $347K | Sell |
1,950
-108
| -5% | -$19.2K | 0.16% | 122 |
|
|
2024
Q3 | $407K | Sell |
2,058
-126
| -6% | -$24.9K | 0.18% | 119 |
|
|
2024
Q2 | $375K | Sell |
2,184
-27
| -1% | -$4.64K | 0.18% | 121 |
|
|
2024
Q1 | $403K | Buy |
2,211
+65
| +3% | +$11.8K | 0.2% | 117 |
|
|
2023
Q4 | $375K | Sell |
2,146
-208
| -9% | -$36.4K | 0.18% | 114 |
|
|
2023
Q3 | $351K | Sell |
2,354
-7
| -0.3% | -$1.04K | 0.2% | 114 |
|
|
2023
Q2 | $318K | Sell |
2,361
-1,007
| -30% | -$136K | 0.18% | 126 |
|
|
2023
Q1 | $537K | Sell |
3,368
-30
| -0.9% | -$4.78K | 0.25% | 112 |
|
|
2022
Q4 | $549K | Buy |
3,398
+3
| +0.1% | +$485 | 0.26% | 107 |
|
|
2022
Q3 | $456K | Sell |
3,395
-713
| -17% | -$95.8K | 0.24% | 114 |
|
|
2022
Q2 | $629K | Buy |
4,108
+673
| +20% | +$103K | 0.27% | 108 |
|
|
2022
Q1 | $557K | Buy |
3,435
+3
| +0.1% | +$486 | 0.22% | 119 |
|
|
2021
Q4 | $465K | Buy |
3,432
+4
| +0.1% | +$542 | 0.19% | 130 |
|
|
2021
Q3 | $370K | Buy |
3,428
+3
| +0.1% | +$324 | 0.17% | 144 |
|
|
2021
Q2 | $386K | Buy |
+3,425
| New | +$386K | 0.18% | 138 |
|
|
2021
Q1 | – | Sell |
-1,999
| Closed | -$214K | – | 162 |
|
|
2020
Q4 | $214K | Buy |
+1,999
| New | +$214K | 0.12% | 151 |
|
|
2020
Q3 | – | Sell |
-2,068
| Closed | -$203K | – | 154 |
|
|
2020
Q2 | $203K | Buy |
+2,068
| New | +$203K | 0.15% | 141 |
|